Small molecule-mediated inhibition of T cell immunoglobulin and mucin domain 3 (TIM-3) as an immunotherapeutic strategy for Acute Myeloid Leukemia (AML) Grant uri icon

Overview

date/time interval

  • January 1, 2023 - December 31, 2024

sponsor award ID

  • ACS 224079-01

Affiliation